BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15626195)

  • 1. Capitalising on global HIV/AIDS funding: the challenge for civil society and government.
    Halmshaw C; Hawkins K
    Reprod Health Matters; 2004 Nov; 12(24):35-41. PubMed ID: 15626195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of national and international HIV/AIDS funding and governance mechanisms on the development of civil-society responses to HIV/AIDS in East and Southern Africa.
    Kelly KJ; Birdsall K
    AIDS Care; 2010; 22 Suppl 2():1580-7. PubMed ID: 21161762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing governance models and funding mechanisms of state-civil society partnerships for HIV/AIDS treatment and prevention based on lessons from Ghana.
    Hushie M
    Afr J AIDS Res; 2019 Jul; 18(2):138-147. PubMed ID: 31282299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expanding role of civil society in the global HIV/AIDS response: what has the President's Emergency Program For AIDS Relief's role been?
    Coutinho A; Roxo U; Epino H; Muganzi A; Dorward E; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S152-7. PubMed ID: 22797737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Civil society organisations and global health initiatives: problems of legitimacy.
    Doyle C; Patel P
    Soc Sci Med; 2008 May; 66(9):1928-38. PubMed ID: 18291566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circus monkeys or change agents? Civil society advocacy for HIV/AIDS in adverse policy environments.
    Spicer N; Harmer A; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Soc Sci Med; 2011 Dec; 73(12):1748-55. PubMed ID: 22036298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.
    Sulzbach S; De S; Wang W
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i72-84. PubMed ID: 21729920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-civil society partnerships for HIV/AIDS treatment and prevention in Ghana: exploring factors associated with successes and challenges.
    Hushie M; Omenyo CN; van den Berg JJ; Lally MA
    BMC Health Serv Res; 2016 Aug; 16():332. PubMed ID: 27484178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcredit for people affected by HIV and AIDS: insights from Kenya.
    Datta D; Njuguna J
    SAHARA J; 2008 Jul; 5(2):94-102. PubMed ID: 18709212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Securitizing HIV/AIDS: a game changer in state-societal relations in China?
    Lo CY
    Global Health; 2018 May; 14(1):50. PubMed ID: 29769102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of health sector non-governmental organizations: policy options.
    Gilson L; Sen PD; Mohammed S; Mujinja P
    Health Policy Plan; 1994 Mar; 9(1):14-24. PubMed ID: 10133097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of aid chains: relations of dependence or supportive partnerships for community-led responses to HIV/AIDS?
    Aveling EL
    AIDS Care; 2010; 22 Suppl 2():1588-97. PubMed ID: 21161763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misfinancing global health: a case for transparency in disbursements and decision making.
    Sridhar D; Batniji R
    Lancet; 2008 Sep; 372(9644):1185-91. PubMed ID: 18926279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014].
    Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337
    [No Abstract]   [Full Text] [Related]  

  • 18. The HIV / AIDS Alliance budgets $23 million for its 3-year plan as "linkman".
    AIDS Anal Afr; 1994; 4(4):3. PubMed ID: 12288158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implementation of a global fund grant in Lesotho: applying a framework on knowledge absorptive capacity.
    Biesma R; Makoa E; Mpemi R; Tsekoa L; Odonkor P; Brugha R
    Soc Sci Med; 2012 Feb; 74(3):381-389. PubMed ID: 21907474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
    Agonnoude MT; Mesenge C
    Sante; 2010; 20(2):116-24. PubMed ID: 20685643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.